Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|March 12, 2005
[Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?]S M Bode-Böger
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 30, 2005
Organic nitrates in cardiovascular diseaseS M Bode-Böger, G Kojda
The American Journal of Physiology|March 1, 1990
Chemotactic peptide FMLP contracts human coronary arteries via cyclooxygenase productsS M Bode, M Kuhn, U Förstermann
Annual Review of Pharmacology and Toxicology|March 27, 2001
The clinical pharmacology of L-arginineR H Böger, S M Bode-Böger
Seminars in Thrombosis and Hemostasis|December 29, 2000
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseasesR H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use]R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance]H Alfke, R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention]R H Böger, S M Bode-Böger, H Alfke
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects]R H Böger, S M Bode-Böger, J C Frölich
Pageof 7